Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

[Research and development policy on bioterrorism medical countermeasures in the United States].

Saito T, Takeuchi T.

Kansenshogaku Zasshi. 2009 Jan;83(1):1-6. Review. Japanese.

PMID:
19227217
2.

Project BioShield: what it is, why it is needed, and its accomplishments so far.

Russell PK.

Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S68-72.

PMID:
17582574
3.
4.

Billions for biodefense: federal agency biodefense funding, FY2001-FY2005.

Schuler A.

Biosecur Bioterror. 2004;2(2):86-96. Review. Erratum in: Biosecur Bioterror. 2004;2(4):344.

PMID:
15225402
5.

Federal agency biodefense funding, FY2012-FY2013.

Franco C, Sell TK.

Biosecur Bioterror. 2012 Jun;10(2):162-81. doi: 10.1089/bsp.2012.0025.

PMID:
22691277
6.

Incentives for biodefense countermeasure development.

Matheny J, Mair M, Mulcahy A, Smith BT.

Biosecur Bioterror. 2007 Sep;5(3):228-38.

PMID:
17903091
7.

Billions for biodefense: federal agency biodefense funding, FY2009-FY2010.

Franco C.

Biosecur Bioterror. 2009 Sep;7(3):291-309. doi: 10.1089/bsp.2009.0035.

PMID:
19772453
8.

Bioterrorism and biological threats dominate federal health security research; other priorities get scant attention.

Shelton SR, Connor K, Uscher-Pines L, Pillemer FM, Mullikin JM, Kellermann AL.

Health Aff (Millwood). 2012 Dec;31(12):2755-63. doi: 10.1377/hlthaff.2012.0311. Review.

PMID:
23213160
9.

Federal agency biodefense funding, FY2013-FY2014.

Sell TK, Watson M.

Biosecur Bioterror. 2013 Sep;11(3):196-216. doi: 10.1089/bsp.2013.0047. Epub 2013 Aug 1.

10.

Strengthening global health security by developing capacities to deploy medical countermeasures internationally.

Marinissen MJ, Barna L, Meyers M, Sherman SE.

Biosecur Bioterror. 2014 Sep-Oct;12(5):284-91. doi: 10.1089/bsp.2014.0049.

11.

Federal agency biodefense funding, FY2010-FY2011.

Franco C, Sell TK.

Biosecur Bioterror. 2010 Jun;8(2):129-49. doi: 10.1089/bsp.2010.0013.

PMID:
20569055
12.

Federal Agency biodefense funding, FY2011-FY2012.

Franco C, Sell TK.

Biosecur Bioterror. 2011 Jun;9(2):117-37. doi: 10.1089/bsp.2011.0018.

PMID:
21612364
13.

Medical countermeasures to protect humans from anthrax bioterrorism.

Bouzianas DG.

Trends Microbiol. 2009 Nov;17(11):522-8. doi: 10.1016/j.tim.2009.08.006. Epub 2009 Sep 24. Review.

PMID:
19781945
14.

Billions for biodefense: federal agency biodefense funding, FY2007-FY2008.

Franco C, Deitch S.

Biosecur Bioterror. 2007 Jun;5(2):117-33.

PMID:
17608598
15.

Medical countermeasures for national security: a new government role in the pharmaceuticalization of society.

Elbe S, Roemer-Mahler A, Long C.

Soc Sci Med. 2015 Apr;131:263-71. doi: 10.1016/j.socscimed.2014.04.035. Epub 2014 Apr 25.

16.

Billions for biodefense: federal agency biodefense budgeting, FY2005-FY2006.

Schuler A.

Biosecur Bioterror. 2005;3(2):94-101.

PMID:
16000040
17.

U.S. budget. Spending triples on terrorism R&D.

Malakoff D.

Science. 2002 Jan 11;295(5553):254. No abstract available.

PMID:
11786619
18.

Strengthening bioterrorism prevention: global biological materials management.

Salerno RM, Hickok LT.

Biosecur Bioterror. 2007 Jun;5(2):107-16.

PMID:
17608597
19.
20.

Anthrax countermeasures: current status and future needs.

Borio LL, Gronvall GK.

Biosecur Bioterror. 2005;3(2):102-12.

PMID:
16000041

Supplemental Content

Support Center